Proactive Investors - Run By Investors For Investors

Collagen Solutions applies for European approval after successful ChondroMimetic study

Jamal Rushdy, chief executive of Collagen Solutions PLC (LON:COS), discusses with Proactive the successful results from an eight-year extension clinical study of patients who received ChondroMimetic® implants for the repair of cartilage defects in the knee.

Rushdy says the positive results have now allowed them to submit an initial submission for a CE Mark.

 
Meet Alliance Pharma plc, IXICO PLC, Benchmark Holdings PLC, Clinigen Group PLC and Shield Therapeutics PLC at our event, London , 24 January 2019. Register here »
View full COS profile View Profile

Collagen Solutions PLC Timeline

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use